Clinical value of liver transplantation for intrahepatic cholangiocarcinoma
10.3760/cma.j.issn.0254-1785.2017.04.001
- VernacularTitle:肝内胆管癌行肝移植术的临床价值
- Author:
Meng SHA
;
Seosong JEONG
;
Jinyang GU
;
Lei XIA
;
Ying TONG
;
Jianjun ZHANG
;
Qiang XIA
- Keywords:
Intrahepatic cholangiocarcinoma;
Hepatic resection;
Liver transplantation;
HBV infection
- From:
Chinese Journal of Organ Transplantation
2017;38(4):193-199
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical value of liver transplantation for intrahepatic cholangiocarcinoma (ICC).Methods A retrospective analysis was performed on 68 patients with ICC who underwent hepatic resection or liver transplantation between January 2007 and September 2013.In the surgical treatment of ICC,overall survival and prognostic risk factors were analyzed to determine the clinical value of liver transplantation for ICC compared with hepatic resection.Results Of the patients with ICC,55 underwent hepatic resection and 13 were given liver transplantation.The 1 and 3-year survival rate was significantly higher in the liver transplantation group than in the hepatic resection group (76.9％ versus 52.7％,and 61.5％ versus 27.3％,P＜0.05).In addition,liver transplantation resulted in higher tumor recurrence-free survival rate than hepatic resection (69.2％ versus 41.8％,and 61.5％ versus 20.0％,P＜0.05).The multivariate analysis showed that tumor size larger than 5 cm was an independent risk factor and HBV infection was an independent protective factor of ICC.Conclusion The prognosis of patients who underwent liver transplantation was better than hepatic resection,suggesting that liver transplantation is perhaps a prior treatment in strictly selected and unresectable patients with ICC.
